SB408124

CAS No. 288150-92-5

SB408124( —— )

Catalog No. M17465 CAS No. 288150-92-5

SB408124 is a non-peptide antagonist for OX1 receptor with Ki of 57 nM and 27 nM in both whole cell and membrane, respectively, exhibits 50-fold selectivity over OX2 receptor.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 45 Get Quote
10MG 73 Get Quote
25MG 162 Get Quote
50MG 291 Get Quote
100MG 431 Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    SB408124
  • Note
    Research use only, not for human use.
  • Brief Description
    SB408124 is a non-peptide antagonist for OX1 receptor with Ki of 57 nM and 27 nM in both whole cell and membrane, respectively, exhibits 50-fold selectivity over OX2 receptor.
  • Description
    SB408124 is a non-peptide antagonist for OX1 receptor with Ki of 57 nM and 27 nM in both whole cell and membrane, respectively, exhibits 50-fold selectivity over OX2 receptor.
  • In Vitro
    ——
  • In Vivo
    SB-408124 (30 μg/10 μl; i.c.v.; male Wistar rats) decreases Orexin-A induced water intake in Wistar rats.
  • Synonyms
    ——
  • Pathway
    MAPK/ERK Signaling
  • Target
    Raf
  • Recptor
    OX1 (membrane)| OX1 (whole cell)
  • Research Area
    Neurological Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    288150-92-5
  • Formula Weight
    356.37
  • Molecular Formula
    C19H18F2N4O
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO : 50 mg/mL 140.30 mM; H2O : < 0.1 mg/mL
  • SMILES
    CN(C)C1=CC=C(NC(=O)NC2=CC(C)=NC3=C(F)C=C(F)C=C23)C=C1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Langmead CJ, et al, Br J Pharmacol, 2004, 141(2) , 340-346.
molnova catalog
related products
  • LY3009120

    LY3009120 (DP-4978) is a potent pan-RAF and RAF dimer inhibitor with IC50 of 5.8, 9.1 and 15 nM for BRAF V600E, BRAF WT and CRAF WT, respectively.

  • I-37

    I-37 is a novel benzylamino substituted pyridopyrimidinone as SOS1 inhibitor.

  • RAF265

    A potent, oral, dual Raf/VEGFR-2 inhibitor with IC50 of 3-60 nM for C-Raf/B-Raf/B-Raf V600E, EC50 of 30 nM for VEGFR2 phosphorylation.